News

The oral, once-daily Zejula (niraparib) tablet, a first-line and recurrent upkeep care for women with advanced epithelial high-grade ovarian, fallopian tube, or primary peritoneal cancer who are in full or partial remission after platinum-based chemotherapy, has been approved by...

The NHS has used its purchasing power to negotiate lower rates for dozens of hospital medications, saving taxpayers £1.2 billion in only three years while obtaining cutting-edge therapies for patients. One third of the savings have been attributable to the...

Abbott informed yesterday, July 3rd, that there are several ways to tell if a customer's pack of Thyronorm is authentic or fake. The label of the product has a QR code that, when scanned, opens a homepage with a...

Recent market analysis predicts that the international market for biopharmaceutical bioseparation systems, which is expected to be worth $13 billion in 2022, will increase to $19.6 billion by 2026, growing at a 13.2% compound annual growth rate (CAGR). According to the...

The Vaccines and Related Biological Products Advisory Panel of the U.S. Food and Drug Administration gathered on June 30th to evaluate whether a change to the COVID-19 vaccine strain composition for booster doses for the fall and winter seasons of...

According to the European Medicines Agency and other international health agencies, coronavirus vaccinations that have been modified to incorporate the omicron variant strain can provide better protection when administered as a booster. Following a meeting on June 30th, the...

The most prevalent kind of the disease, non-small cell lung cancer, has seen steady advancements in immunotherapies called checkpoint inhibitors during the past ten years. First, medications like Keytruda from Merck & Co., Opdivo from Bristol-Myers Squibb, and Tecentriq...